MRAs in Patients With AMI Without Early Evidence of Heart Failure: Time for Reappraisal?
Division of Cardiology, University of Michigan School of Medicine, Ann Arbor, Michigan. Electronic address: bpitt@umich.edu.
Bertram
B
Pitt
D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy; D013148:Spironolactone / Q000627:therapeutic use; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy
D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone
left ventricular dysfunction; mineralocorticoid receptor antagonists; mortality; myocardial infarction